FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Novavax logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
The Biden administration purchased 3.2 million doses of Novavax’s protein-based coronavirus vaccine in July 2022 shortly before the Food and Drug Administration (FDA) authorized the shot for administration.
Unlike the vaccines made by Pfizer and Moderna, the Novavax vaccine is a more traditional form of immunization, containing inert fragments of the virus meant to help develop an immune response.
At the time of the acquisition, the White House highlighted the shot as additional option for people to get vaccinated.
“This agreement acknowledges the need to offer the American people a diverse COVID-19 vaccine portfolio and underscores the importance of Novavax’ partnership with the U.S. government to ensure continuous access to a protein-based option as part of public health measures,” Novavax President and CEO John C. Jacobs said in a statement.
According to federal data, roughly 77,500 doses of Novavax’s COVID-19 vaccine have been administered out of the more than 1 million doses that have been delivered so far.
Full Link ( Here )
© CopyRights RawNews1st
